Fractyl Health, Inc. SEC filings GUTS
Fractyl Health, Inc. has 227 filings in SEC EDGAR's recent list, going back to Mar 21, 2013. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (exit or restructuring costs, officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Other events
|
Oct 22, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 16, 2026 | Oct 16, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 1, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 24, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 11, 2026 | Sep 10, 2026 |
| DEF 14A | Proxy statement | Aug 24, 2026 | Aug 24, 2026 |
| PRE 14A | Preliminary proxy statement | Aug 14, 2026 | Sep 24, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 15, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 4, 2026 | Jun 4, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 11, 2026 | May 11, 2026 |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Apr 23, 2026 |
| 10-K | Annual report | Mar 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 24, 2026 | Mar 24, 2026 |
| 8-K |
Current report
Listing notice
|
Mar 17, 2026 | Mar 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 29, 2026 | Jan 29, 2026 |
| S-8 | Employee stock plan registration | Jan 13, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 6, 2026 | Dec 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 5, 2026 | Jan 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 16, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 2, 2025 | Dec 2, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Oct 3, 2025 | Oct 3, 2025 |
| 424B5 | Prospectus supplement | Sep 26, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 26, 2025 | Sep 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 26, 2025 | Sep 26, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 3, 2025 | Aug 29, 2025 |
| DEF 14A | Proxy statement | Aug 25, 2025 | Oct 3, 2025 |
| PRE 14A | Preliminary proxy statement | Aug 15, 2025 | Oct 3, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 7, 2025 | Aug 6, 2025 |
| 424B5 | Prospectus supplement | Aug 7, 2025 | — |
| 424B5 | Prospectus supplement | Aug 5, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 23, 2025 | Jun 23, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 18, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 19, 2025 | May 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 19, 2025 | May 17, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 24, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 24, 2025 | — |
| DEF 14A | Proxy statement | Apr 24, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 1, 2025 | Apr 1, 2025 |
| EFFECT | Filing | Mar 18, 2025 | — |
| CORRESP | Letter to the SEC | Mar 13, 2025 | — |
| S-3/A | Filing | Mar 13, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 13, 2025 | Mar 13, 2025 |
| UPLOAD | Letter from the SEC | Mar 11, 2025 | — |
| S-3 | Shelf registration | Mar 3, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 3, 2025 | Mar 3, 2025 |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Jan 31, 2025 | Jan 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 30, 2024 | Jul 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 24, 2024 | Jun 24, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 1, 2024 | Apr 1, 2024 |
| S-8 | Employee stock plan registration | Feb 6, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Feb 6, 2024 | Feb 6, 2024 |
| 424B4 | Prospectus | Feb 2, 2024 | — |
| SEC STAFF LETTER | Filing | Feb 1, 2024 | — |
| EFFECT | Filing | Feb 1, 2024 | — |
| CERT | Filing | Feb 1, 2024 | — |
| CORRESP | Letter to the SEC | Jan 30, 2024 | — |
| CORRESP | Letter to the SEC | Jan 30, 2024 | — |
| 8-A12B | Filing | Jan 29, 2024 | — |
| CORRESP | Letter to the SEC | Jan 29, 2024 | — |
| S-1/A | Amended registration statement | Jan 29, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2023 | — |
| SEC STAFF LETTER | Filing | Dec 19, 2023 | — |
| CORRESP | Letter to the SEC | Dec 14, 2023 | — |
| S-1 | Registration statement | Dec 14, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 3, 2023 | — |
| DRS/A | Filing | Sep 21, 2023 | — |
| DRSLTR | Filing | Sep 21, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2023 | — |
| DRS/A | Filing | Aug 22, 2023 | — |
| DRS/A | Filing | Apr 4, 2022 | — |
| DRSLTR | Filing | Feb 3, 2022 | — |
| DRS/A | Filing | Feb 3, 2022 | — |
| D | Filing | Jan 25, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2022 | — |
| DRS/A | Filing | Jan 12, 2022 | — |
| DRSLTR | Filing | Jan 11, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2022 | — |
| DRSLTR | Filing | Dec 20, 2021 | — |
| DRS/A | Filing | Dec 20, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 14, 2021 | — |
| DRS | Filing | Nov 9, 2021 | — |
| D | Filing | Jun 22, 2021 | — |
| D | Filing | Mar 19, 2020 | — |
| D/A | Filing | Dec 15, 2017 | — |
| D | Filing | Jul 5, 2017 | — |
| D/A | Filing | Feb 19, 2016 | — |
| D | Filing | Nov 6, 2015 | — |
| D | Filing | Sep 3, 2014 | — |
| D | Filing | Mar 21, 2013 | — |
Showing 115 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- GUTS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Burlington, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1572616
- Former names
- Fractyl Laboratories Inc. (until Mar 19, 2020)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.